In the BioHarmony Drug Report Database
Leronlimab
Leronlimab is an antibody pharmaceutical. It is currently being investigated in clinical studies. It is known to target C-C chemokine receptor type 5.
Trade Name
|
|
|---|---|
Common Name
|
leronlimab |
ChEMBL ID
|
CHEMBL2109343 |
Indication
|
|
Drug Class
|
Monoclonal antibodies: immunomodulating |
Image (chem structure or protein)
